MoonLake Immunotherapeutics Deferred Costs, Noncurrent
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2026-08-10
- 2026-06-30: Deferred Costs, Noncurrent $1.34M.
- 2026-03-31: Deferred Costs, Noncurrent $1.34M.
- 2025-12-31: Deferred Costs, Noncurrent $587.00K.
- 2025-09-30: Deferred Costs, Noncurrent $587.00K.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2026-06-30 | $1.34M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $1.34M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $587.00K 10-Q · filed 2026-08-10 |
| 2025-09-30 | $587.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.70M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.70M 10-Q · filed 2025-05-12 |